Dose: 0.357 to 0.714 mg/kg
Single Dose: 0.54 (0.5355)
Frequency: 24 hourly
Route: PO
Instructions: -

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Synthetic origin and belongs to Sulphonylurea. It belongs to Potassium Channel (ATP sensitive) antagonist pharmacological group on the basis of mechanism of action and also classified in Antidiabetic Agent, Sulfonylurea pharmacological group.The Molecular Weight of Glibornuride is 366.50. Its pKa is 4.7.

Glibornuride is contraindicated in conditions like Renal diseases,Hepatic disease,Iddm,Diabetic coma.

Glibornuride produces potentially life-threatening effects which include Hypoglycemia, Hypoglycemia, Hypoglycemia. which are responsible for the discontinuation of Glibornuride therapy.The signs and symptoms that are produced after the acute overdosage of Glibornuride include Coma, Drowsiness, Confusion, Hypoglycemia, Sweating, Restlessness, Hunger, Trembling.The symptomatic adverse reactions produced by Glibornuride are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Confusion, SweatingX, Confusion.

Glibornuride is primarily indicated in conditions like Type II diabetes mellitus.

No data regarding the interactions of Glibornuride was found.

Altered liver euzyme valueNo effects on blood levels

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.